Navigation Links
New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
Date:5/18/2008

Additional Digestive Disease Week data highlight effects of AMITIZA in

patients with IBS-C

SAN DIEGO, May 18 /PRNewswire/ -- New study results indicated that treatment with AMITIZA(R) (lubiprostone) 8 mcg lead to significant relief of overall symptoms of Irritable Bowel Syndrome with Constipation (IBS-C). These results were presented at Digestive Disease Week (DDW) 2008, the largest annual international meeting of digestive disease specialists.

"IBS-C is a multi-symptom disorder and is one of the most common conditions seen by gastroenterologists," said William D. Chey, M.D., primary investigator of the study, University of Michigan Health System. "These data are important because they show that in studies, AMITIZA has demonstrated the ability to improve the overall symptoms reported by patients with IBS-C."

AMITIZA 8 mcg was approved by the U.S. Food and Drug Administration (FDA) on April 29, 2008 for the treatment of IBS-C in women 18 years of age and older, and has been approved since 2006 at a 24 mcg dose for the treatment of Chronic Idiopathic Constipation in adults. These data were among others presented at DDW 2008 that evaluated the effect of AMITIZA for IBS-C.

"AMITIZA is the first ClC-2 channel activator and the only widely available FDA-approved agent for the treatment of IBS-C in adult women in the United States. AMITIZA could provide overall symptom relief for the millions of appropriate patients in the U.S. who suffer from this condition," said Ryuji Ueno, M.D., Ph.D., Ph.D., founder, chairman and chief executive officer, Sucampo Pharmaceuticals (Nasdaq: SCMP). "We are pleased with the body of data on AMITIZA presented at DDW this year. Additional data presented at thi
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.; SucampoPharmaceuticals,
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
2. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
3. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
5. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
6. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
7. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
8. Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047
9. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Armada Health Care ... organization (GPO), is pleased to announce an agreement ... a host of innovative specialty pharmacy patient program ... enhanced therapy management services to specialty patients via ... Aurora will use the OTM platform ...
(Date:8/21/2014)... Aug. 21, 2014 /CNW/ - Bedrocan Cannabis Corp., previously ... members to its Board of Directors, enhancing executive ... the company, a leading licensed producer of medicinal ... Bedrocan has 13 years, experience in producing and ... countries, including Canada. As previously ...
(Date:8/21/2014)... Pa. , Aug. 21, 2014   ... ), a specialty biopharmaceutical company, today announced positive ... of collagenase clostridium histolyticum (or CCH) for the ... as cellulite. In the Phase 2a trial, all ... and high (0.84mg)) showed an improvement in the ...
Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7
... 2011 Accuray Incorporated (Nasdaq: ARAY ), the ... an investor meeting on Monday, October 3, at the annual ... Miami Beach, Florida. The meeting is open to institutional investors ... breakfast meeting, beginning at 7:00 a.m. E.D.T. on Monday, October ...
... Crowds of politicians, patients and physicians gathered on the ... Sula, Honduras, last week to celebrate the inauguration of ... para Ninos Quemados y Cirugia Pediatrica Ruth Paz. The ... Honduras and in Central America. The facility,s establishment was ...
Cached Medicine Technology:Accuray Incorporated to Host Investor Meeting at ASTRO 2011 2Carolinas HealthCare System (CHS) Contributes to First Children's Burn Hospital in Central America 2Carolinas HealthCare System (CHS) Contributes to First Children's Burn Hospital in Central America 3
(Date:8/22/2014)... The rising numbers of teenage substance abuse ... countless lives have been lost due to adolescent drug and ... a new helpline was established to provide a valuable source ... are seeking to overcome their chemical dependency issues. , ... parents and their teens can speak immediately to a representative ...
(Date:8/22/2014)... 2014 According to the market ... Adaptive Cruise Control (ACC) System Market for Passenger ... - 2019", published by MarketsandMarkets, classifies and defines ... terms of volume and value. The report highlights ... well as covers review of the market drivers, ...
(Date:8/21/2014)... August 22, 2014 Os-Monitor.com, an ... unveiled its new employee monitoring software collection ( ... has also announced that all these high end ... , With the tendency of improving productivity, the ... efficiency than before. Thus, employee and network monitoring ...
(Date:8/21/2014)... 22, 2014 Strongly influenced by ... even when there are no consequences, researchers in ... found. , This could imply that humans are ... of others, researchers said. Their findings are published ... humans’ sense of unfairness is affected by their ...
(Date:8/21/2014)... UWDress.com, a well-known wedding dress manufacturer, has added a ... online store. In addition to this, all these beautiful gowns ... off) at the moment. The special offer will last from ... online workers have updated its online category with these affordable, ... website is a one stop place where worldwide people can ...
Breaking Medicine News(10 mins):Health News:Troubled Teens in Akron, OH Can Receive Assistance from New Helpline for Addiction Recovery 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 4Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Beautiful Peacock Party Dresses for 2014 Offered by UWDress.com at the Moment 2
... MediKeeper,( http://www.medikeeper.com ), a leading provider of enabling ... to announce the,launch of its new HealthPage application ... personalized health homepage or "personal,health URL" for consumers ... health and the health of their family., ...
... announces the,availability of TraderNotes on stocks that are making ... daily trading notes for free by visiting:, http://www.BeaconEquity.com/m , ... LLSR),Elbit Imaging Ltd. (Nasdaq: EMITF ), Biolase Technology ... Bulletin Board: OISI), Alcon Inc.,(NYSE: ACL ), Luminex ...
... In First Acquisition Since Investment from IAC/InterActive Corp, ... of Patient Engagement Capabilities, ARLINGTON, Va., June ... announced today the acquisition of consumer health,information company ... size,of HealthCentral,s email newsletter reach and offers advertisers ...
... University researchers are calling on clinicians to adopt a ... was published in the June edition of Primary ... M.D., noted that quantified measurement of outcome is rarely ... of treatment it is necessary to evaluate outcome. It ...
... June 10, 2008 Various intervention strategies have been ... factor that might affect exposure to interventionsis gender. A ... Psychology reviewed the behavior of participants exposed to ... women were likely to avoid gender-mismatched brochures. Women, however, ...
... ... ,What the h--- have I ... - Marcia Cross, Morning sickness can strike at any time and last all day - ... and engineered to meet the special dietary needs of,women who are pregnant, nursing or trying ...
Cached Medicine News:Health News:MediKeeper Forms Alliance With Microsoft's HealthVault 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 3Health News:The HealthCentral Network Acquires MedTrackAlert, Extending its Ability to Reach Highly Engaged Online Health Consumers 2Health News:The HealthCentral Network Acquires MedTrackAlert, Extending its Ability to Reach Highly Engaged Online Health Consumers 3Health News:The HealthCentral Network Acquires MedTrackAlert, Extending its Ability to Reach Highly Engaged Online Health Consumers 4Health News:A call for standardized measurement of outcomes in depression treatment 2Health News:Gender affects reaction to HIV-prevention materials 2Health News:Oh Mama! Heads Back to the Lab to Create the First Ever Ginger-Ale for Moms-To-Be 2
The lower body blanket is designed to be used primarily during surgery on the upper half of the body....
This blanket is ideal for warming the large child or small adult during upper body surgery....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: